Document is current
Any future updates will be listed below
-
Authors
Verma, Nishant
Le, Todd
Mudge, Jonah
Nicksic, Peter J.
Xistris, Lillian
Kasole, Maisha
Shoffstall, Andrew J.
Poore, Samuel O.
Ludwig, Kip A.
Dingle, Aaron M.
- License Information
-
More Information
Article History
Received: 28 June 2022
Accepted: 12 December 2022
First Online: 16 December 2022
Competing interests
: NV is an employee of Abbott Neuromodulation and BioCircuit Technologies. KAL is a scientific board member and has stock interests in NeuroOne Medical Inc. KAL is also a paid member of the scientific advisory boards of Cala Health, Blackfynn, Abbott Neuromodulation, and Battelle. KAL also is a paid consultant for Galvani, Boston Scientific, CVRx, Presidio Medical, and the Alfred Mann Foundation. KAL and AJS are co-founders of Neuronoff Inc., which is commercializing the Injectrode. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
